Wegovy Tablets: Initial dose (days 1 through 30): 1.5 mg orally once a day Dose escalation: Days 31 through 60: 4 mg orally once a day Days 61 through 90: 9 mg orally once a day SUBCUTANEOUS: Ozempic Injection: Initial dose: 0.25 mg subcutaneously once a week for 4 weeks, then 0.5 mg subcutaneously once a week Maintenance dose for glycemic control: 0.5 to 2 mg subcutaneously once a week, based on glycemic control If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dose: Increase to 1 mg subcutaneously once a week
Other symptoms may include difficulty breathing and nausea
Kureshi at Kureshi Weight Loss & Medspa in McKinney, TX, offers Semaglutide GLP-1 weight loss injections as part of a comprehensive approach to weight management
Symptoms of NAION and Sudden Vision Loss NAION often develops without warning and typically causes sudden, painless vision loss in one eye due to reduced blood flow to the optic nerve
(5.7) Acute Gallbladder Disease: If cholelithiasis or cholecystitis are suspected, gallbladder studies are indicated
If you are also taking insulin or sulfonylureas and experiencing reduced food intake due to digestive symptoms, monitor your blood glucose closely as you may be at risk of hypoglycaemia